Table of Content

1 Report Overview
1.1 Abdominal Aortic Aneurysm Drug Definition
1.2 Market by Type
1.2.1 Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 BSN-908
1.2.3 Canakinumab
1.2.4 CT-2009
1.2.5 Ticagrelor
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Abdominal Aortic Aneurysm Drug Sales
2.1 Global Abdominal Aortic Aneurysm Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Abdominal Aortic Aneurysm Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Abdominal Aortic Aneurysm Drug Revenue by Region
2.3.1 Global Abdominal Aortic Aneurysm Drug Revenue by Region (2018-2023)
2.3.2 Global Abdominal Aortic Aneurysm Drug Revenue by Region (2024-2034)
2.4 Global Abdominal Aortic Aneurysm Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Abdominal Aortic Aneurysm Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Abdominal Aortic Aneurysm Drug Sales Quantity by Region
2.6.1 Global Abdominal Aortic Aneurysm Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Abdominal Aortic Aneurysm Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Abdominal Aortic Aneurysm Drug Sales Quantity by Manufacturers
3.1.1 Global Abdominal Aortic Aneurysm Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Abdominal Aortic Aneurysm Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Abdominal Aortic Aneurysm Drug Sales in 2024
3.2 Global Abdominal Aortic Aneurysm Drug Revenue by Manufacturers
3.2.1 Global Abdominal Aortic Aneurysm Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Abdominal Aortic Aneurysm Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Abdominal Aortic Aneurysm Drug Revenue in 2024
3.3 Global Abdominal Aortic Aneurysm Drug Sales Price by Manufacturers
3.4 Global Key Players of Abdominal Aortic Aneurysm Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Abdominal Aortic Aneurysm Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Abdominal Aortic Aneurysm Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Abdominal Aortic Aneurysm Drug, Product Offered and Application
3.8 Global Key Manufacturers of Abdominal Aortic Aneurysm Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Abdominal Aortic Aneurysm Drug Sales Quantity by Type
4.1.1 Global Abdominal Aortic Aneurysm Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Abdominal Aortic Aneurysm Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Abdominal Aortic Aneurysm Drug Revenue by Type
4.2.1 Global Abdominal Aortic Aneurysm Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Abdominal Aortic Aneurysm Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2018-2034)
4.3 Global Abdominal Aortic Aneurysm Drug Price by Type
4.3.1 Global Abdominal Aortic Aneurysm Drug Price by Type (2018-2023)
4.3.2 Global Abdominal Aortic Aneurysm Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Abdominal Aortic Aneurysm Drug Sales Quantity by Application
5.1.1 Global Abdominal Aortic Aneurysm Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Abdominal Aortic Aneurysm Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Abdominal Aortic Aneurysm Drug Revenue by Application
5.2.1 Global Abdominal Aortic Aneurysm Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Abdominal Aortic Aneurysm Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2018-2034)
5.3 Global Abdominal Aortic Aneurysm Drug Price by Application
5.3.1 Global Abdominal Aortic Aneurysm Drug Price by Application (2018-2023)
5.3.2 Global Abdominal Aortic Aneurysm Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Abdominal Aortic Aneurysm Drug Sales by Company
6.1.1 North America Abdominal Aortic Aneurysm Drug Revenue by Company (2018-2023)
6.1.2 North America Abdominal Aortic Aneurysm Drug Sales Quantity by Company (2018-2023)
6.2 North America Abdominal Aortic Aneurysm Drug Market Size by Type
6.2.1 North America Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Abdominal Aortic Aneurysm Drug Revenue by Type (2018-2034)
6.3 North America Abdominal Aortic Aneurysm Drug Market Size by Application
6.3.1 North America Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Abdominal Aortic Aneurysm Drug Revenue by Application (2018-2034)
6.4 North America Abdominal Aortic Aneurysm Drug Market Size by Country
6.4.1 North America Abdominal Aortic Aneurysm Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Abdominal Aortic Aneurysm Drug Revenue by Country (2018-2034)
6.4.3 North America Abdominal Aortic Aneurysm Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Abdominal Aortic Aneurysm Drug Sales by Company
7.1.1 Europe Abdominal Aortic Aneurysm Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Abdominal Aortic Aneurysm Drug Revenue by Company (2018-2023)
7.2 Europe Abdominal Aortic Aneurysm Drug Market Size by Type
7.2.1 Europe Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Abdominal Aortic Aneurysm Drug Revenue by Type (2018-2034)
7.3 Europe Abdominal Aortic Aneurysm Drug Market Size by Application
7.3.1 Europe Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Abdominal Aortic Aneurysm Drug Revenue by Application (2018-2034)
7.4 Europe Abdominal Aortic Aneurysm Drug Market Size by Country
7.4.1 Europe Abdominal Aortic Aneurysm Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Abdominal Aortic Aneurysm Drug Revenue by Country (2018-2034)
7.4.3 Europe Abdominal Aortic Aneurysm Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Abdominal Aortic Aneurysm Drug Sales by Company
8.1.1 China Abdominal Aortic Aneurysm Drug Sales Quantity by Company (2018-2023)
8.1.2 China Abdominal Aortic Aneurysm Drug Revenue by Company (2018-2023)
8.2 China Abdominal Aortic Aneurysm Drug Market Size by Type
8.2.1 China Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2018-2034)
8.2.2 China Abdominal Aortic Aneurysm Drug Revenue by Type (2018-2034)
8.3 China Abdominal Aortic Aneurysm Drug Market Size by Application
8.3.1 China Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2018-2034)
8.3.2 China Abdominal Aortic Aneurysm Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Abdominal Aortic Aneurysm Drug Sales by Company
9.1.1 APAC Abdominal Aortic Aneurysm Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Abdominal Aortic Aneurysm Drug Revenue by Company (2018-2023)
9.2 APAC Abdominal Aortic Aneurysm Drug Market Size by Type
9.2.1 APAC Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Abdominal Aortic Aneurysm Drug Revenue by Type (2018-2034)
9.3 APAC Abdominal Aortic Aneurysm Drug Market Size by Application
9.3.1 APAC Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Abdominal Aortic Aneurysm Drug Revenue by Application (2018-2034)
9.4 APAC Abdominal Aortic Aneurysm Drug Market Size by Region
9.4.1 APAC Abdominal Aortic Aneurysm Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Abdominal Aortic Aneurysm Drug Revenue by Region (2018-2034)
9.4.3 APAC Abdominal Aortic Aneurysm Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Information
11.1.2 AstraZeneca Plc Overview
11.1.3 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Products and Services
11.1.5 AstraZeneca Plc Abdominal Aortic Aneurysm Drug SWOT Analysis
11.1.6 AstraZeneca Plc Recent Developments
11.2 Carolus Therapeutics, Inc.
11.2.1 Carolus Therapeutics, Inc. Company Information
11.2.2 Carolus Therapeutics, Inc. Overview
11.2.3 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Products and Services
11.2.5 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug SWOT Analysis
11.2.6 Carolus Therapeutics, Inc. Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Overview
11.3.3 Novartis AG Abdominal Aortic Aneurysm Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Novartis AG Abdominal Aortic Aneurysm Drug Products and Services
11.3.5 Novartis AG Abdominal Aortic Aneurysm Drug SWOT Analysis
11.3.6 Novartis AG Recent Developments
11.4 Vida Therapeutics Inc.
11.4.1 Vida Therapeutics Inc. Company Information
11.4.2 Vida Therapeutics Inc. Overview
11.4.3 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Products and Services
11.4.5 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug SWOT Analysis
11.4.6 Vida Therapeutics Inc. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Abdominal Aortic Aneurysm Drug Value Chain Analysis
12.2 Abdominal Aortic Aneurysm Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Abdominal Aortic Aneurysm Drug Production Mode & Process
12.4 Abdominal Aortic Aneurysm Drug Sales and Marketing
12.4.1 Abdominal Aortic Aneurysm Drug Sales Channels
12.4.2 Abdominal Aortic Aneurysm Drug Distributors
12.5 Abdominal Aortic Aneurysm Drug Customers
13 Market Dynamics
13.1 Abdominal Aortic Aneurysm Drug Industry Trends
13.2 Abdominal Aortic Aneurysm Drug Market Drivers
13.3 Abdominal Aortic Aneurysm Drug Market Challenges
13.4 Abdominal Aortic Aneurysm Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of BSN-908
Table 3. Major Manufacturers of Canakinumab
Table 4. Major Manufacturers of CT-2009
Table 5. Major Manufacturers of Ticagrelor
Table 6. Major Manufacturers of Others
Table 7. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Abdominal Aortic Aneurysm Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Abdominal Aortic Aneurysm Drug Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2018-2023)
Table 11. Global Abdominal Aortic Aneurysm Drug Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2024-2034)
Table 13. Global Abdominal Aortic Aneurysm Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 14. Global Abdominal Aortic Aneurysm Drug Sales by Region (2018-2023) & (K Pcs)
Table 15. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2018-2023)
Table 16. Global Abdominal Aortic Aneurysm Drug Sales by Region (2024-2034) & (K Pcs)
Table 17. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2024-2034)
Table 18. Global Abdominal Aortic Aneurysm Drug Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 19. Global Abdominal Aortic Aneurysm Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 20. Global Abdominal Aortic Aneurysm Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Abdominal Aortic Aneurysm Drug Revenue Share by Manufacturers (2018-2023)
Table 22. Global Abdominal Aortic Aneurysm Drug Price by Manufacturers 2018-2023 (USD/Pcs)
Table 23. Global Key Players of Abdominal Aortic Aneurysm Drug, Industry Ranking, 2021 VS 2024
Table 24. Global Abdominal Aortic Aneurysm Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Abdominal Aortic Aneurysm Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Abdominal Aortic Aneurysm Drug as of 2024)
Table 26. Global Key Manufacturers of Abdominal Aortic Aneurysm Drug, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Abdominal Aortic Aneurysm Drug, Product Offered and Application
Table 28. Global Key Manufacturers of Abdominal Aortic Aneurysm Drug, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 31. Global Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 32. Global Abdominal Aortic Aneurysm Drug Sales Quantity Share by Type (2018-2023)
Table 33. Global Abdominal Aortic Aneurysm Drug Sales Quantity Share by Type (2024-2034)
Table 34. Global Abdominal Aortic Aneurysm Drug Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Abdominal Aortic Aneurysm Drug Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Abdominal Aortic Aneurysm Drug Revenue Share by Type (2018-2023)
Table 37. Global Abdominal Aortic Aneurysm Drug Revenue Share by Type (2024-2034)
Table 38. Abdominal Aortic Aneurysm Drug Price by Type (2018-2023) & (USD/Pcs)
Table 39. Global Abdominal Aortic Aneurysm Drug Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 40. Global Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 41. Global Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 42. Global Abdominal Aortic Aneurysm Drug Sales Quantity Share by Application (2018-2023)
Table 43. Global Abdominal Aortic Aneurysm Drug Sales Quantity Share by Application (2024-2034)
Table 44. Global Abdominal Aortic Aneurysm Drug Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Abdominal Aortic Aneurysm Drug Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Abdominal Aortic Aneurysm Drug Revenue Share by Application (2018-2023)
Table 47. Global Abdominal Aortic Aneurysm Drug Revenue Share by Application (2024-2034)
Table 48. Abdominal Aortic Aneurysm Drug Price by Application (2018-2023) & (USD/Pcs)
Table 49. Global Abdominal Aortic Aneurysm Drug Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 50. North America Abdominal Aortic Aneurysm Drug Revenue by Company (2018-2023) & (US$ Million)
Table 51. North America Abdominal Aortic Aneurysm Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 52. North America Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 53. North America Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 54. North America Abdominal Aortic Aneurysm Drug Revenue by Type (2018-2023) & (US$ Million)
Table 55. North America Abdominal Aortic Aneurysm Drug Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 57. North America Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 58. North America Abdominal Aortic Aneurysm Drug Revenue by Application (2018-2023) & (US$ Million)
Table 59. North America Abdominal Aortic Aneurysm Drug Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Abdominal Aortic Aneurysm Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 61. North America Abdominal Aortic Aneurysm Drug Revenue by Country (2018-2023) & (US$ Million)
Table 62. North America Abdominal Aortic Aneurysm Drug Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Abdominal Aortic Aneurysm Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 64. North America Abdominal Aortic Aneurysm Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 65. Europe Abdominal Aortic Aneurysm Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 66. Europe Abdominal Aortic Aneurysm Drug Revenue by Company (2018-2023) & (US$ Million)
Table 67. Europe Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 68. Europe Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 69. Europe Abdominal Aortic Aneurysm Drug Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Abdominal Aortic Aneurysm Drug Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 72. Europe Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 73. Europe Abdominal Aortic Aneurysm Drug Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Abdominal Aortic Aneurysm Drug Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Abdominal Aortic Aneurysm Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 76. Europe Abdominal Aortic Aneurysm Drug Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Abdominal Aortic Aneurysm Drug Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Abdominal Aortic Aneurysm Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 79. Europe Abdominal Aortic Aneurysm Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 80. China Abdominal Aortic Aneurysm Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 81. China Abdominal Aortic Aneurysm Drug Revenue by Company (2018-2023) & (US$ Million)
Table 82. China Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 83. China Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 84. China Abdominal Aortic Aneurysm Drug Revenue by Type (2018-2023) & (US$ Million)
Table 85. China Abdominal Aortic Aneurysm Drug Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 87. China Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 88. China Abdominal Aortic Aneurysm Drug Revenue by Application (2018-2023) & (US$ Million)
Table 89. China Abdominal Aortic Aneurysm Drug Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Abdominal Aortic Aneurysm Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 91. APAC Abdominal Aortic Aneurysm Drug Revenue by Company (2018-2023) & (US$ Million)
Table 92. APAC Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 93. APAC Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 94. APAC Abdominal Aortic Aneurysm Drug Revenue by Type (2018-2023) & (US$ Million)
Table 95. APAC Abdominal Aortic Aneurysm Drug Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 97. APAC Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 98. APAC Abdominal Aortic Aneurysm Drug Revenue by Application (2018-2023) & (US$ Million)
Table 99. APAC Abdominal Aortic Aneurysm Drug Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Abdominal Aortic Aneurysm Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 101. APAC Abdominal Aortic Aneurysm Drug Revenue by Region (2018-2023) & (US$ Million)
Table 102. APAC Abdominal Aortic Aneurysm Drug Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Abdominal Aortic Aneurysm Drug Sales Quantity by Region (2018-2023) & (K Pcs)
Table 104. APAC Abdominal Aortic Aneurysm Drug Sales Quantity by Region (2024-2034) & (K Pcs)
Table 105. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 106. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue by Company (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 108. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 109. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue by Type (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 112. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 113. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue by Application (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue by Country (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 119. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 120. AstraZeneca Plc Company Information
Table 121. AstraZeneca Plc Description and Overview
Table 122. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 123. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Product and Services
Table 124. AstraZeneca Plc Abdominal Aortic Aneurysm Drug SWOT Analysis
Table 125. AstraZeneca Plc Recent Developments
Table 126. Carolus Therapeutics, Inc. Company Information
Table 127. Carolus Therapeutics, Inc. Description and Overview
Table 128. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 129. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Product and Services
Table 130. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug SWOT Analysis
Table 131. Carolus Therapeutics, Inc. Recent Developments
Table 132. Novartis AG Company Information
Table 133. Novartis AG Description and Overview
Table 134. Novartis AG Abdominal Aortic Aneurysm Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 135. Novartis AG Abdominal Aortic Aneurysm Drug Product and Services
Table 136. Novartis AG Abdominal Aortic Aneurysm Drug SWOT Analysis
Table 137. Novartis AG Recent Developments
Table 138. Vida Therapeutics Inc. Company Information
Table 139. Vida Therapeutics Inc. Description and Overview
Table 140. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 141. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Product and Services
Table 142. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug SWOT Analysis
Table 143. Vida Therapeutics Inc. Recent Developments
Table 144. Key Raw Materials Lists
Table 145. Raw Materials Key Suppliers Lists
Table 146. Abdominal Aortic Aneurysm Drug Distributors List
Table 147. Abdominal Aortic Aneurysm Drug Customers List
Table 148. Abdominal Aortic Aneurysm Drug Market Trends
Table 149. Abdominal Aortic Aneurysm Drug Market Drivers
Table 150. Abdominal Aortic Aneurysm Drug Market Challenges
Table 151. Abdominal Aortic Aneurysm Drug Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Abdominal Aortic Aneurysm Drug Product Picture
Figure 2. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Abdominal Aortic Aneurysm Drug Market Share by Type in 2024 & 2034
Figure 4. BSN-908 Product Picture
Figure 5. Canakinumab Product Picture
Figure 6. CT-2009 Product Picture
Figure 7. Ticagrelor Product Picture
Figure 8. Others Product Picture
Figure 9. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 10. Global Abdominal Aortic Aneurysm Drug Market Share by Application in 2024 & 2034
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Others
Figure 14. Abdominal Aortic Aneurysm Drug Report Years Considered
Figure 15. Global Abdominal Aortic Aneurysm Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Abdominal Aortic Aneurysm Drug Revenue 2018-2034 (US$ Million)
Figure 17. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 18. Global Abdominal Aortic Aneurysm Drug Sales Quantity 2018-2034 (K Pcs)
Figure 19. Global Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Region (2018-2023)
Figure 20. Global Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Abdominal Aortic Aneurysm Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 22. North America Abdominal Aortic Aneurysm Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Abdominal Aortic Aneurysm Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. Europe Abdominal Aortic Aneurysm Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Abdominal Aortic Aneurysm Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. China Abdominal Aortic Aneurysm Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Abdominal Aortic Aneurysm Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. APAC Abdominal Aortic Aneurysm Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 30. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Abdominal Aortic Aneurysm Drug Sales Quantity in 2024
Figure 32. The Top 10 and Top 5 Players Market Share by Abdominal Aortic Aneurysm Drug Revenue in 2024
Figure 33. Abdominal Aortic Aneurysm Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 34. Global Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2018-2034)
Figure 36. Global Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2018-2034)
Figure 38. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Company in 2024
Figure 39. North America Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Company in 2024
Figure 40. North America Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2018-2034)
Figure 42. North America Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2018-2034)
Figure 44. North America Abdominal Aortic Aneurysm Drug Revenue Share by Country (2018-2034)
Figure 45. North America Abdominal Aortic Aneurysm Drug Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Company in 2024
Figure 49. Europe Abdominal Aortic Aneurysm Drug Revenue Market Share by Company in 2024
Figure 50. Europe Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2018-2034)
Figure 52. Europe Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2018-2034)
Figure 54. Europe Abdominal Aortic Aneurysm Drug Revenue Share by Country (2018-2034)
Figure 55. Europe Abdominal Aortic Aneurysm Drug Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 57. France Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 61. China Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Company in 2024
Figure 62. China Abdominal Aortic Aneurysm Drug Revenue Market Share by Company in 2024
Figure 63. China Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2018-2034)
Figure 65. China Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2018-2034)
Figure 67. APAC Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Company in 2024
Figure 68. APAC Abdominal Aortic Aneurysm Drug Revenue Market Share by Company in 2024
Figure 69. APAC Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2018-2034)
Figure 71. APAC Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2018-2034)
Figure 73. APAC Abdominal Aortic Aneurysm Drug Revenue Share by Region (2018-2034)
Figure 74. APAC Abdominal Aortic Aneurysm Drug Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 79. India Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Abdominal Aortic Aneurysm Drug Revenue Share by Country (2018-2034)
Figure 88. Brazil Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Abdominal Aortic Aneurysm Drug Revenue (2018-2034) & (US$ Million)
Figure 93. Abdominal Aortic Aneurysm Drug Value Chain
Figure 94. Abdominal Aortic Aneurysm Drug Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed